Hemorrhagic fever

Common Name(s)

Hemorrhagic fever

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Hemorrhagic fever" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Hemorrhagic fever" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Hemorrhagic fever" returned 576 free, full-text research articles on human participants. First 3 results:

Epidemic hemorrhagic fever complicated with late pregnancy: A case report.
 

Author(s): Xiao-Li Liu, Dong Hao, Xiao-Zhi Wang, Tao Wang, Feng Lu, Weili Liu, Bingjie Lv, Chang-Jun Lv

Journal: Medicine (Baltimore). 2017 Oct;96(40):e8137.

 

Hantaviruses cause two forms of diseases in humans, namely hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome. Hantavirus infections can occur in pregnant women, and could influence the maternal and fetal outcomes, although this is a rare finding, even in endemic areas.

Last Updated: 6 Oct 2017

Go To URL
A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models.
 

Author(s): Aura R Garrison, Charles J Shoemaker, Joseph W Golden, Collin J Fitzpatrick, John J Suschak, Michelle J Richards, Catherine V Badger, Carolyn M Six, Jacqueline D Martin, Drew Hannaman, Marko Zivcec, Eric Bergeron, Jeffrey W Koehler, Connie S Schmaljohn

Journal:

 

Crimean-Congo hemorrhagic fever virus (CCHFV) is a tick-borne virus capable of causing a severe hemorrhagic fever disease in humans. There are currently no licensed vaccines to prevent CCHFV-associated disease. We developed a DNA vaccine expressing the M-segment glycoprotein precursor ...

Last Updated: 18 Sep 2017

Go To URL
Infection prevention and control practice for Crimean-Congo hemorrhagic fever-A multi-center cross-sectional survey in Eurasia.
 

Author(s): Tom E Fletcher, Abuova Gulzhan, Salih Ahmeti, Seif S Al-Abri, Zahide Asik, Aynur Atilla, Nick J Beeching, Heval Bilek, Ilkay Bozkurt, Iva Christova, Fazilet Duygu, Saban Esen, Arjun Khanna, Çiğdem Kader, Masoud Mardani, Faisal Mahmood, Nana Mamuchishvili, Natalia Pshenichnaya, Mustafa Sunbul, Tuğba Y Yalcin, Hakan Leblebicioglu

Journal:

 

Crimean Congo Hemorrhagic Fever (CCHF) is a life threatening acute viral infection that presents significant risk of nosocomial transmission to healthcare workers.

Last Updated: 8 Sep 2017

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Hemorrhagic fever" returned 48 free, full-text review articles on human participants. First 3 results:

Crimean-Congo hemorrhagic fever in pregnancy: A systematic review and case series from Russia, Kazakhstan and Turkey.
 

Author(s): Natalia Yurievna Pshenichnaya, Hakan Leblebicioglu, Ilkay Bozkurt, Irina Viktorovna Sannikova, Gulzhan Narkenovna Abuova, Andrey Sergeevich Zhuravlev, Sener Barut, Mutabar Bekovna Shermetova, Tom E Fletcher

Journal: Int. J. Infect. Dis.. 2017 May;58():58-64.

 

Crimean-Congo hemorrhagic fever (CCHF) is acute viral infection and a major emerging infectious diseases threat, affecting a large geographical area. There is no proven antiviral therapy and it has a case fatality rate of 4-30%. The natural history of disease and outcomes of CCHF ...

Last Updated: 2 Mar 2017

Go To URL
Novel strategies for development of hemorrhagic fever arenavirus live-attenuated vaccines.
 

Author(s): Luis Martinez-Sobrido, Juan Carlos de la Torre

Journal: Expert Rev Vaccines. 2016 Sep;15(9):1113-21.

 

Several arenaviruses, chiefly Lassa virus (LASV), cause hemorrhagic fever (HF) disease in humans and pose significant public health problems in their endemic regions. Moreover, HF arenaviruses represent credible biodefense threats. There are not FDA-approved arenavirus vaccines and ...

Last Updated: 19 Aug 2016

Go To URL
Molecular Insights into Crimean-Congo Hemorrhagic Fever Virus.
 

Author(s): Marko Zivcec, Florine E M Scholte, Christina F Spiropoulou, Jessica R Spengler, Éric Bergeron

Journal:

 

Crimean-Congo hemorrhagic fever virus (CCHFV) is a tick-borne pathogen that causes high morbidity and mortality. Efficacy of vaccines and antivirals to treat human CCHFV infections remains limited and controversial. Research into pathology and underlying molecular mechanisms of CCHFV ...

Last Updated: 26 Apr 2016

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Last Updated: 6 Nov 2017

Go to URL

Last Updated: 9 Oct 2017

Go to URL